DEMARINIS, R. M.;SHAH, D. H.;HALL, R. F.;HIEBLE, J. P.;PENDLETON, R. G., J. MED. CHEM., 1982, 25, N 2, 136-141
作者:DEMARINIS, R. M.、SHAH, D. H.、HALL, R. F.、HIEBLE, J. P.、PENDLETON, R. G.
DOI:——
日期:——
[EN] DIMETHOXYPHENYLALKYLAMINE ACTIVATORS OF SEROTONIN RECEPTORS<br/>[FR] ACTIVATEURS DE DIMÉTHOXYPHÉNYLALKYLAMINE DE RÉCEPTEURS DE LA SÉROTONINE
申请人:[en]ATAI LIFE SCIENCES AG
公开号:WO2022261240A2
公开(公告)日:2022-12-15
Provided herein are compounds of Formula (I), or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and n are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) or pharmaceutically acceptable salt thereof, and methods of using a compound of Formula (I) or pharmaceutically acceptable salt thereof, e.g., in the treatment of a mental health disease or disorder.